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ABSTRACT
Toxin-antitoxin (TA) loci encode inhibitors of
translation, replication or cell wall synthesis and
are common elements of prokaryotic plasmids and
chromosomes. Ten TA loci of Escherichia coli K-12
encode mRNases that cumulatively contribute to
persistence (multidrug tolerance) of the bacterial
cells. The mechanisms underlying induction and re-
version of the persistent state are not yet under-
stood. The vapBC operon of Salmonalla enterica
serovar Typhimurium LT2 encodes VapC, a tRNase
that reversibly inhibits translation by site-specific
cleavage of tRNA
fMet. VapB is an antitoxin that inter-
acts with and neutralizes VapC via its C-terminal tail
and regulate TA operon transcription via its
N-terminal DNA binding domain that recognize op-
erators in the vapBC promoter region. We show
here that transcription of the vapBC operon of S.
enterica is controlled by a recently discovered
regulatory theme referred to as ‘conditional
cooperativity’: at low T/A ratios, the TA complex
binds cooperatively to the promoter region and
represses TA operon transcription whereas at high
T/A ratios, the excess toxin leads to destabilization
of the TA-operator complex and therefore, induction
of transcription. We present evidence that an excess
of VapC toxin leads to operator complex destabil-
ization by breaking of toxin dimers.
INTRODUCTION
Prokaryotic chromosomes and plasmids encode a plethora
of toxin–antitoxin (TA) loci that belong to three different
types. In type I TA loci, the antitoxin is a cis-encoded
antisense RNA that inhibits translation of a toxin-
encoding mRNA (1,2). In type II loci, the antitoxin is
a protein that combines with and neutralizes the cognate
toxin (3). Finally, in type III loci, the antitoxin is an RNA
that combines with and neutralizes the toxin (4). Type II
TA loci are common and, based on toxin sequence
similarities, have been divided into evolutionary independ-
ent gene families (5,6). Three of these families, vapBC,
relBE and hicAB are common in both bacteria and
archaea (5,7,8). Of these three families, vapBC loci are
particularly abundant: of approximately 3825 TA loci
identiﬁed in 900 prokaryotic genomes, approximately
1300 were vapBC loci (9). In some organisms, the
numbers of TA loci are particularly high. Remarkably,
Mycobacterium tuberculosis has at least 88 type II TA
loci, 45 of which are vapBC homologues (10). The
reason for the large expansions of TA loci in particular
organisms is not known.
TA loci have been linked to several biological func-
tions, such as plasmid and gene stabilization (11,12)
and environmental stresses, such as amino acid starva-
tion (13). It has also been suggested that TA loci have no
biological function (14). However, recently we showed
that, in the model organism Escherichia coli, TA loci
were required for bacterial persistence (15). Thus, pro-
gressive deletion of type II TA loci gradually reduced the
persistence level and deletion of 10 TA loci encoding
RNA endonucleases reduced persistence approximately
200-fold.
Even though the different families of type II TA loci
have independent evolutionary origins their regulation and
genetic organization are remarkably similar. In almost all
cases, a TA locus consists of two closely linked genes, one
of which encodes the antitoxin and the other the toxin.
Although rare exceptions exists (16,17), transcription of
almost all type II TA operons is autoregulated by the
TA complex that binds to one or more operators in the
TA promoter region. The TA complex binds to DNA via
a domains present in the antitoxin. Usually, the toxin
enhances the binding of the antitoxin to the operator
(3). The DNA domains belong to four different classes:
Helix–Turn–Helix (HTH), Ribbon–Helix–Helix (RHH),
AbrB and Phd/YefM (3). In the vapBC and relBE gene
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binding motifs, indicating that domain shufﬂing took
place during the evolution of these gene families (6).
In actively growing cells, the TA operators are occupied
by cognate TA complexes and transcription of the
operons is repressed (13,18–22). The antitoxins are meta-
bolically unstable due to degradation by cellular prote-
ases. For example, Lon degrades RelB antitoxin of E.
coli (13). In growing cells, de novo synthesis of RelB
replenishes the RelB pool and relBE translation stays
repressed. In contrast, when translation is reduced by,
e.g. amino acid starvation, the RelB level is reduced.
Consequently, the TA promoter is activated (13).
In turn, the increased transcription-rate of relBE leads
to partial replenishment of the antitoxin pool after an
initial delay (13,23). Even though the antitoxin level is
restored to 50% of the initial pre-starvation level, the
transcription-rate of the TA operon stays unexpectedly
high during amino acid starvation (13). More in-depth
analysis revealed that transcription of relBE is regulated
by the RelB/RelE ratio such that when [RelB]>[RelE],
two RelB2 RelE complexes bind strongly and coopera-
tively to two operators (relO) overlapping the relBE
promoter sequences and repress transcription (23).
In contrast, when [RelB]<[RelE], the excess RelE
invades the RelB2 RelE relO complex and abolishes co-
operative binding, probably via the formation of a
RelB2 RelE2 tetramer that does not bind cooperatively
to relO. By this mechanism that we called ‘conditional
cooperativity’, the RelB/RelE ratio controls the
transcription-rate of relBE (23). In turn, the RelB/RelE
ratio is controlled by the interplay of the relBE
translation-rate and the degradation-rate of RelB that is
determined by Lon. Transcription of the phd doc and ccd
operons of plasmid P1 and F is also regulated by condi-
tional cooperativity (24,36). That evolutionarily unrelated
TA loci are regulated by conditional cooperativity by dif-
ferent molecular mechanisms indicates that this peculiar
mode of transcriptional regulation is a biologically im-
portant property of TA loci.
Here we investigate if conditional cooperativity controls
transcription of an enteric vapBC locus. VapC toxins from
enterobacteria are tRNases that inhibit global translation
by site-speciﬁc cleavage of tRNA
fMet between the anti-
codon stem and loop (25). As with other TA loci,
VapBC complexes bind to operators in the promoter
regions and autoregulate transcription (26–28). Structural
analysis of VapBC from Neisseria gonorrhoeae (also called
FitAB) showed that an octamer of four VapB–VapC
heterodimers [(VapBC)2]2 binds to operator DNA via an
RHH motif in VapB (29), consistent with autoregulation
of vapBC transcription by VapBC.
We show that VapB of Salmonella enterica serovar
Typhimurium LT2 that contains an AbrB-like DNA-
binding motif is degraded by the ATP-dependent Lon
protease. When translation is inhibited, VapB decays
and vapBC promoter activity increases, consistent with
transcriptional autoregulation by VapB. Indeed, VapB
binds to two operator sequences (vapO1 and vapO2)i n
the promoter region in vitro and this binding is strongly
enhanced by VapC. Remarkably, an excess of VapC
decreases the afﬁnity of the VapBC complex for DNA
and, consistently, increases transcription-rate in vivo.
Structural modelling and mutational analysis allow us to
propose a novel mechanism of conditional cooperativity
in which excess VapC toxin induces vapBC transcription
by breaking of VapC dimers.
MATERIALS AND METHODS
Media, antibiotics, strains and plasmids
Bacteria were grown in Luria–Bertani medium (LB)
as described (30). When required, the medium was
supplemented with 30 or 100mg/ml ampicillin, 50mg/ml
chloramphenicol, 25mg/ml kanamycin. X-gal (5-bromo-
4-chloro-3-indoyl-b-D-galactoside) was added to a ﬁnal
concentration of 40mg/ml. Expression of proteins from
the PA1/O4/O3 or PBAD promoters was induced by 2mM
isopropylb-D-thiogalactopyranoside (IPTG) or 0.2%
arabinose, respectively. Strains and plasmids are listed
in Supplementary Table S1 and oligonucleotides in
Supplementary Table S2, respectively.
Puriﬁcation of VapB and VapC proteins
VapC and VapB were puriﬁed essentially according to
(25). Strain C41 containing pKW512HB, pKW512HB
L43A, pKW512HBI44A, pKW512HBY72A, pKW512
HBA76S or pKW512HC was grown exponentially under
aeration in LB at 37 C. At OD450=0.5, expression was
induced by addition of 2mM IPTG. After 3h of growth,
the culture was harvested and resuspended in ice-cold lysis
buffer (50mM NaH2PO4, 0.3M NaCl, 10mM imidazole,
5mM b-mercaptoethanol pH8 supplemented with
EDTA-free protease inhibitor, Roche). Cells were dis-
rupted using a Constant Cell disruption system and
lysate cleared by centrifugation at 15000 rpm for 30 min
at 4 C. The cleared lysate was then incubated with
Ni-NTA agarose (Qiagen) for at least 2h at 4 C and sub-
sequently loaded onto a gravity column. The column was
washed extensively in wash buffer (50mM NaH2PO4,
0.3M NaCl, 35mM imidazole, 5mM b-mercaptoethanol
pH 8). VapC or VapB was then eluted from complex
under denaturing conditions by incubating the column
overnight (ON) at room-temperature in 10 column
volumes of denaturing buffer (100mM NaH2PO4,
10mM Tris–HCl, 9.8M Urea, pH8). Denatured protein
was refolded by four-step dialysis; (i) 1 PBS 0.1% Triton
X-100 5mM DTT, (ii) 1 PBS 5mM DTT, (iii) 1 PBS
5mM DTT and (iv) 1  PBS 20% glycerol 1mM DTT.
The authenticity and purity was veriﬁed by SDS–PAGE.
Electrophoretic mobility shift assays and DNase I
footprinting
DNA fragments were constructed containing either one
binding site vapO1 (using hybridized oligos VapBC
binding#small-down and VapBCbinding#small-up) or
two binding sites, vapO1 and vapO2 (PCR product with
oligos vapBC_EMSA_down and vapBC_EMSA_up).
Prior to the hybridization and PCR reaction VapBC
binding#small-down or vapBC_EMSA_down were
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Kinase (New England Biolabs). Binding site mutations in
vapO1 and vapO2 were introduced by PCR using primers
PBC-10_MUT_DOWN and PBC-10_MUT_UP for site 1
and PBC-35_MUT_DOWN and PBC-35_MUT_UP for
site 2. Labelled probes (0.5–2nM) were incubated with
puriﬁed proteins in binding buffer (20mM Tris–HCl pH
7.5, 100mM KCl, 2mM MgCl2, 1mM DTT, 50mg/ml
BSA and 10% glycerol) to avoid unspeciﬁc DNA
binding sonicated salmon sperm DNA (ssDNA) was
added to a ﬁnal concentration 0.1mg/ml. Reactions were
incubated for 20 min at 37 C before DNA bound
complexes were separated by native PAGE in 5% or 6%
acrylamide gels with 0.5  TBE for two and one binding
site probes, respectively. The separation was followed by
phosphorimaging.
For DNase I footprinting, samples were incubated with
0.01U/ml DNase I and 1 DNase I buffer (Roche) at
37 C for 2 min, followed by addition of 100ml of Stop
buffer (2 M ammonium acetate, 20mM EDTA, 10mg/
ml ssDNA). The resulting DNA fragments were extracted
once in phenol, once in chloroform, precipitated in
ethanol and separated on an 8% denaturing acrylamide
gel along with a dideoxyNTP sequencing ladder. The
digestion pattern was analysed by to phosphorimaging.
RESULTS
VapB autoregulates vapBC transcription and is degraded
by Lon protease
VapB of S. enterica LT2 (STM3034) contains an AbrB
DNA binding domain in its N-terminus (31), raising the
possibility that VapB autoregulates vapBC transcription
via binding to two inverted repeats in the promoter
region that we call vapO1 and vapO2 (Figure 1A). The
entire operator was called vapO. Previously, we showed
that amino acid starvation induces vapBC transcription
(32). We examined vapBC transcription using primer ex-
tension analysis of RNA prepared from strains S. enterica
LT2 (KP1001) or E. coli K-12 (MG1655, wt) carrying
vapBC on a low-copy-number plasmid before and after
the inhibition of translation by the addition of chloram-
phenicol. As seen from Figure 1B, the level of transcripts
increased in both strains. Transcription also increased in
strain MG1655clpP but not in the isogenic lon strain,
suggesting that Lon protease degrades VapB. To test this
inference directly, we measured VapB levels. As seen from
Figure 1C, VapB decayed rapidly in wt and clp but not
in the lon strain. Thus, Lon degrades VapB. The
increased mRNA level seen after inhibition of translation
with chloramphenicol suggested that VapB autoregulates
Figure 1. Lon degrades VapB and is required for activation of vapBC transcription. (A) DNA sequence of the vapBC promoter region showing  10
and  35 promoter sequences and the two operators vapO1 and vapO2 as inverted repeats. (B) Primer extension analysis of the 50-end of vapBC
mRNA. Strains MG1655 (E. coli K-12, wt), KW10 (MG1655Dlon) or KW11 (MG1655DclpP) containing pKW71512 (pNDM71::vapBC) and
KP1001 (S. enterica LT2) were grown exponentially in LB medium. At time zero, chloramphenicol (50mg/ml) was added and cell samples were
withdrawn at the time points indicated (min). Total RNA was extracted and reverse transcription was performed using primer vapB-5#PE. (C)
Western blotting analysis of VapB. MG1655 KW10 or KW11 containing pKW51 (pA1/03/04::SDopt::vapB) were grown exponentially in LB medium.
Ten minutes before the addition of chloramphenicol (50mg/ml; t0 =0), 1 mM IPTG was added to induce vapB. Samples were taken at the time points
indicated and VapB detected by polyclonal antibodies directed towards VapB.
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vapO2 that overlap with the  10 and  35 promoter
sequences, respectively (Figure 1A).
VapC enhances binding of VapB to vapO1 and vapO2
Native VapB and VapC were puriﬁed and used in gel shift
analysis to probe their binding to vapO. VapB alone
formed a complex with vapO-encoding DNA (C1 and
C2 in Figure 2A); however only at very high concentra-
tions more signiﬁcant DNA–VapB complexes were
observed (lanes 3–7). In contrast, VapB did not bind to
a control DNA fragment (P in Figure 2A). Thus, VapB
has low but speciﬁc afﬁnity for vapO. In contrast, VapC
alone bound neither to the vapO fragment (U) nor to the
control fragment (lane 8). However, addition of VapC to a
low concentration of VapB yielded an increase in complex
formation that further increased dramatically with
increasing concentration of VapC (lanes 9–13). Thus,
VapC enhances the binding of VapB to vapO.
Interestingly, at very high concentrations, VapB alone
produced a complex with a mobility similar to that
generated by VapBC (Figure 2A, comp. lanes 3–7 with
lanes 9–14). This could be due to the presence of a small
amount of VapC in the VapB preparation or because the
complexes were complexes are not resolved in this experi-
mental setup.
Next, we performed foot printing analysis of the
complex bound to vapO. DNA was incubated with a
constant concentration of VapB and increasing concentra-
tions of VapC and digested with DNase I (Figure 2B,
lanes 1–4). Two protected regions overlapping with the
two inverted repeats appeared, consistent with VapBC
binding to vapO1 and vapO2. This observation raised
the possibility that complexes C1 and C2 observed in the
gel shift analysis (Figure 2A) corresponded to one and two
VapBC complexes bound to vapO, respectively. Most
importantly, increasing the concentration of VapC
increased VapB binding to operator DNA.
An excess of VapC releases VapBC from operator DNA
At a VapB/VapC ratio of  2/16 in the gel shift analysis
shown in Figure 2A, the amount of C2 complex decreased
modestly in intensity while that of C1 increased (lane 14),
thus raising the possibility that very high concentrations
of VapC destabilized the VapBCO complex. To investi-
gate this phenomenon further, we performed gel shift and
foot printing analysis with higher concentrations of VapC.
As before, increasing [VapC] increased VapB speciﬁc
binding to vapO (Figure 3A, lanes 2 and 3). However,
increasing [VapC] further severely reduced binding (lanes
4–8) with almost no VapBC bound at a B/C ratio of 1/16
(lane 8). To investigate if the destabilization of VapBC
binding to vapO was reversible, we then increased the
VapB/VapC ratio by increasing [VapB] while keeping
[VapC] constant (lanes 9–11). We observed a resulting
increase in binding to vapO, consistent with a reversible
and direct effect of VapC.
DNase I foot printing yielded more detailed informa-
tion. First, at high [VapC], vapO1 and vapO2 were both
protected (Figure 3B, lane 2); however, vapO1 was clearly
protected better than vapO2 and an increase of [VapC]
released VapBC binding at vapO2 before vapO1 (lanes
2–7). When the VapB/VapC ratio was increased, protec-
tion was regained (lanes 8 and 9). Again, vapO1 was pro-
tected at a lower concentration of VapB (lane 8) than
vapO2 (lane 9), consistent with higher afﬁnity of the
VapBC complex for vapO1.
Figure 2. VapC increases the afﬁnity of VapB for vapO-encoding DNA. (A) VapB and VapBC complex binding to vapO analysed by gel shifting.
Puriﬁed VapB and VapC were added to a 302-bp
32P-labelled vapO DNA probe (labelled U in the gel) and a 199-bp mock DNA fragment derived
from pUC19 (labelled P). Concentrations of VapB and VapC are given below each lane (mM). C1 and C2 denote the inferred VapBC vapO
complexeses. (B) VapBC binding to a vapO-encoding DNA fragment analysed by DNase I protection. Puriﬁed VapB and VapC were added to
the same DNA probe as in (A) and subsequently incubated with DNase I (lanes 1–4). The protected regions are enclosed by boxes and the positions
of the transcriptional start site and the two inverted repeats are marked with arrows.
4350 Nucleic Acids Research, 2012,Vol.40, No. 10An excess of VapC stimulates vapBC transcription
The above-described results showed that excess VapC
destabilized the VapBCO complex and predicted that an
excess of VapC in living cells would derepress the vapBC
promoter. To test this, we fused vapBC transcriptionally
to the lacZ gene. Induction in trans of vapC
D7A, encoding
a non-toxic VapC
D7A variant, increased LacZ expression
from the vapBC::lacZ transcriptional fusion (Figure 3C).
Induction of vapBC by excess VapC
D7A was conﬁrmed by
quantitative RT-PCR measurements (Figure 3D). After
300 of induction of vapC
D7A, the transcription rate of
vapBC::lacZ had increased  3-fold. No increase
was observed with the control plasmid. This result was
consistent with the VapC-mediated destabilization of
the VapBCO complex seen in vitro. Thus, vapBC operon
transcription is regulated by conditional cooperativity
in vivo.
One operator site is sufﬁcient for regulation by
conditional cooperativity
The deﬁnition of conditional cooperativity in TA locus
regulation entails cooperative binding of the TA
complex to the promoter when the antitoxin is in excess
and release of the complex when the toxin is in excess
(23,24). To investigate the function of vapO1 and vapO2
in the cooperative binding of VapBC to vapO,w e
introduced mutations in the half-sites of vapO1 and
vapO2, respectively (Figure 4A). To avoid interference
with promoter activity, the mutations were located away
from the  10 and  35 promoter sequences (see below).
First, we analysed vapO1
Mut and vapO2
Mut in gel shift
assays (Figure 4B). As before, a vapO
wt fragment
generated two complexes (C1 and C2) that decreased in
intensity with increasing concentration of VapC. The
vapO1
Mut and vapO2
Mut fragments exhibited changed
patterns: the C2 complex disappeared (vapO2
Mut) or was
highly reduced (vapO1
Mut). This pattern supported that
the C1 and C2 complexes corresponded to vapO bound
with one and two VapBC complexes, respectively. Most
importantly, however, complex formation was in both
cases again reduced when VapC was increased. This
result suggested that a single vapO operator was sufﬁcient
for transcriptional regulation by conditional
cooperativity. The fact that C1 complexes formed by
vapO1
Mut and vapO2
Mut migrate so similarly suggests
that the VapBC protein complexes formed on either
vapO1 or vapO2 are identical. A fragment carrying the
double vapO12
Mut mutation hardly bound VapBC at all,
although a faint C1 complex was observed that most
likely reﬂected incomplete disruption of VapBC bound
to the vapO1
Mut. This inference is also consistent with
the weak C2 complex seen with the vapO1
Mut fragment.
Nevertheless, the vapO1 mutation decreased the amount
of complex formation more than the vapO2 mutation,
consistent with the observation that the VapBC complex
has the highest afﬁnity for vapO1.
To investigate the effect of the vapO mutations
(Figure 4A) on transcriptional repression in vivo,
we again used transcriptional vapBC-lacZ fusions
(Figure 4C). The double vapO1
Mut and vapO2
Mut mutant
(vapO12
Mut) caused a strong derepression of vapBC tran-
scription, consistent with the lack of VapBC binding to
the operator sites seen in vitro. The single vapO mutations
also derepressed vapBC transcription, but to a much lesser
Figure 3. The vapBC promoter is controlled by conditional
cooperativity. (A) Binding of VapB and VapBC complex to a vapO-
encoding DNA fragment analysed by gel shifting. Puriﬁed VapB and
VapC were added to a 302-bp
32P-labelled vapO probe (lanes 1–11;
numbers below the gel are innM). Protein–DNA complexes were
separated by 5% native PAGE. U denotes unbound vapO DNA and
C1 and C2 VapBCO complexes. (B) DNase I protection assay of vapO.
VapB and VapC were incubated with vapO DNA as in (A) and sub-
sequently incubated with DNase I (lanes 1–9; numbers are pmol). A
DNA sequencing ladder was generated using 50-end labelled
vapBC_EMSA_down primer. Inverted repeats sites 1 and 2 and
promoter sequences are indicated by arrows. DNAse I protected
bases are enclosed by boxes. (C) Ectopic expression of VapC
D7A
in vivo induces vapBC transcription. TB28 (MG1655DlacIZYA)
pKW512TFZD7A (vapBC
D7A::lacZYA) containing either
pKW3353HC (pBAD::SDopt::vapC
D7A) or pBAD33 were streaked to
single colonies on LB plates containing X-gal and 0.2% arabinose.
(D) VapC
D7A induced transcription quantiﬁed by qPCR. TB28
(MG1655 DlacIZYA) pKW512TFZD7A (vapBC
D7A::lacZYA) with
pKW3353HC (pBAD::SDopt::vapC
D7A-H6) or pBAD33 (empty vector
plasmid) were grown exponentially in LB medium. At 00, arabinose was
added to induce transcription from the pBAD promoter. Samples were
taken at time points indicated (min) and total RNA extracted.
Fold-of-changes relative to house keeping gene rpsA mRNA were
measured by quantitative RT-PCR.
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Mut yielded stronger derepression than
vapO2
Mut, consistent with higher afﬁnity of VapBC for
vapO1 (Figure 4B). Importantly, these observations
showed that vapO1 and vapO2 can function independently
to regulate vapBC transcription.
The above-described results raised the possibility that a
fragment containing one VapBC binding site would
respond with conditional cooperativity at increased
VapC/VapB ratios. To test this, we performed gel shift
assays using a DNA fragment containing only vapO1
(Figure 4D). As before, increasing [VapC] increased
VapB binding (lanes 2–5). As before, at increased VapC/
VapB ratios (2/16, lane 6), binding was reduced and ﬁnally
totally abolished (lanes 9–11). In these reactions, binding
could also be regained by increasing the concentration of
VapB (lanes 12–14). Quantiﬁcation showed the dramatic
changes in VapBC binding as a function of the VapC/
VapB ratio (Figure 4D).
Figure 4. One vapBC operator is sufﬁcient for regulation by conditional cooperativity. (A) DNA sequences of the vapBC promoter region showing
the base substitutions in vapO1
Mut, vapO2
Mut and vapO12
Mut. Inverted repeats are indicated by arrows and promoter sequences by  10 and  35,
respectively. (B) Gel shift assay of VapBC complex binding to the DNA fragments shown in (A). VapB and VapC were incubated with DNA
(numbers are innM) . U indicates unbound DNA fragment, C1 and C2 are fragments bound by either one or two VapBC complexes, respectively.
(C) vapBC promoter activity in binding site mutants. TB28 (MG1655DlacIZYA) containing either Pwt::vapBC
D7A::lacZYA (pKW512TFZD7A),
P::vapO1
Mut::vapBC
D7A::lacZYA (pKW512TFZD7A-1), P::vapO2
Mut::vapBC
D7A::lacZYA (pKW512TFZD7A-2) or P::vapO1
Mut::vapO2
Mut::
vapBC
D7A::lacZYA (pKW512TFZD7A-1-2) were grown exponentially in LB medium at 37 C. At an OD600 of approximately 0.5, samples were collected
and LacZ activity measured (Miller Units). (D) Gel shift analysis as in (B) but with a promoter DNA fragment (36 bp) containing only vapO1. Numbers
below the gel are protein concentrations innM (lane 1–14). Protein–DNA complexes were separated by 6% native PAGE. U and C indicate positions of
unbound and bound DNA, respectively. Insert at right: Quantiﬁcation of the C band-intensities (%) in the gel-shift shown at left.
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The crystal structure of a VapBC homologous complex of
N. gonorrhoea (FitAB, fast intracellular trafﬁcking)
revealed an octamer of four VapBC heterodimers
[(VapBC)2]2 bound to operator DNA (Supplementary
Figure S1D) (29). In this structure, VapC form bridges
between two VapB dimers bound to operator half-sites.
The structure readily explains why VapC mediates strong
cooperative binding of VapB to operator DNA (29).
More recently, the crystal structure of the VapBC
complex from Shigella ﬂexneri 2a YSH6000 virulence
plasmid pMYSH6000 (VapBCS.ﬂex) was solved, revealing
a similar but more compact structure (Supplementary
Figure S1C) (33). This observation implies that VapBC
complexes in general form octameric complexes. For the
S. enterica proteins, the theoretical molecular weight of a
[(VapBC)2]2 octamer is 93.2kD. Our estimation of the size
of the VapBC complex bound to vapO1 was 92±10kD
(Supplementary Figure S2A–S2D). We infer that VapBC
of S. enterica also binds as an octameric [(VapBC)2]2
complex to operator DNA. A similar complex is very
likely also formed at vapO2.
The FitAB crystal structure (Supplementary Figure S1C
and S1D) predicts that VapC dimerization is essential for
cooperative binding of the [(VapBC)2]2 complex to vapO.
Therefore, the VapC mediated destabilization of the
[(VapBC)2]2 vapO1 complex can be explained by
breaking of the VapC dimer by an excess of VapC (see
Discussion). We modelled the tertiary structure of VapC
using Phyre (34) and aligned the predicted structure with
VapCS.ﬂex and FitB (Supplementary Figure S1B). The
primary sequences of VapC and FitB exhibit low similar-
ity (22% identical, 41% similar, Supplementary Figure
S1A). However, a VapC dimer aligned well with the
FitB dimer in the tetrameric [(FitAB)2]2 DNA complex
and with the VapCS.ﬂex dimer in S. ﬂexneri [(VapBC)2]2
complex (Supplementary Figure S1C and S1D). The
modelled structure of the VapC dimer is shown in
Figure 5A. This model predicted two patches in VapC
to be involved in dimerization. The effect of changing
these residues to alanine (or to serine in one case) on
vapBC transcription was measured using a vapBC::lacZ
transcriptional fusion (Figure 5B). Changing four
residues L43A, I44A, Y72A and A76S individually signiﬁ-
cantly increased vapBC transcription (5.2-, 1.4-, 7.0- and
1.9-fold, respectively). The activity of the vapBC
Y72A::lacZ
fusion was similar to that of a vapBC::lacZ fusion
carrying mutations in both operator sites (comp. Figures
4B and 5C), indicating that the Y72A substitution in
VapC resulted in complete loss of repression by the
VapBC complex. The tertiary structure alignments
showed that tyrosine 72 of VapC and VapCS.ﬂex corres-
ponds to phenylalanine 78 in FitB, a key residue for FitB
dimerization (Supplementary Figure S1B) (29). These
results support that VapC dimerization is important for
repression of vapBC transcription by the VapBC complex.
To challenge this inference directly, we asked if the
Y72A mutation would affect VapC dimerization. As
seen from Supplementary Figure S3, indeed the Y72A
mutation abolished dimerization of puriﬁed VapC. Thus,
we conclude that dimerization of VapC is required for
repression of the vapBC promoter by the VapBC complex.
Mutations in the VapC dimer interface abolish conditional
cooperativity
The VapC
Y72A variant that was defective in dimerization
yielded a possibility to test directly, in vitro, if indeed
VapC dimerization is required for efﬁcient binding of
VapBC to vapO DNA. More importantly, however, we
could also test if conditional cooperativity depends on
VapC dimerization. We used puriﬁed VapB, VapC and
VapC
Y72A (Figure 5C). As expected, low concentrations
of wild-type VapC increased binding of VapB to vapO1
and higher concentrations destabilized the complex. A
dramatically different pattern was seen with VapC
Y72A.
First, a much higher concentration of VapC
Y72A was
required to yield efﬁcient binding, consistent with the pre-
diction that VapC dimers bridges two VapB dimers bound
to operator DNA. However, strikingly, high concentra-
tions of VapC
Y72A did not destabilize the VapBC
Y72A
complex. On the contrary, increasing [VapC
Y72A] led to
a strong increase in binding. VapC variants carrying other
changes in the dimerization patches (VapC
Y72A,
VapC
L43A, VapC
I44A and VapC
A76S) behaved similarly
although less dramatic (Supplementary Figure S4). The
reduced capability of VapC
L43A and VapC
A76S to
increase binding of VapB to vapO1 (Supplementary
Figure S4) is consistent with the increased transcription
rates of vapBC loci carrying the corresponding alleles
(Figure 5B). These observations show that not only is di-
merization of VapC crucial for cooperative binding of
VapB2 to vapO but also for excess VapC to destabilize
VapBCO.
DISCUSSION
We show here that vapBC of S. enterica is under complex
transcriptional regulation by VapB and VapC: in the
presence of an excess of VapB, VapC induced avid and
cooperative binding of the VapBC complex to vapO
operator DNA whereas an excess of VapC destabilized
VapBCO (Figures 2–4). Band shifting with a vapO DNA
fragment encoding both vapO1 and vapO2 yielded two
different nucleoprotein complexes (Figure 2A) and muta-
tions in vapO1 or vapO2 abolished VapBC binding at the
mutated vapO operator but not at the other, intact
operator (Figure 4B). Consistently, foot printing analysis
revealed that the VapBC protected regions corresponding
to vapO1 and vapO2 (Figures 2B and 3B). We conclude
that the VapBC complex binds cooperatively to vapO1
and vapO2 in the presence of excess VapB.
In contrast, an excess of VapC destabilized VapBC
binding to both vapO1 and vapO2 (Figure 3A and B)
and, consistently, overexpression of a non-toxic variant
of VapC in living cells stimulated transcription (Figure
3C and D). Transcription of vapBC is thus regulated by
conditional cooperativity. Remarkably, a DNA fragment
carrying only one operator (vapO1) responded similarly,
showing that the two operator sites function
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conditional cooperativity (Figure 4B and D). The vapO1
fragment bound a complex with a molecular weight con-
sistent with the binding of an octamer of four VapB–VapC
heterodimers [(VapBC)2]2, a stoichiometry similar to that
of a VapBC (FitAB) complex from N. gonorrhoea bound
to DNA (29). In this complex, VapB dimers bound to each
operator half-site are bridged by VapC dimers
(Supplementary Figure S1D). A similar stoichiometry
has also recently been shown for the DNA-bound
VapBC complex of Rickettsia felis (35). In addition,
Brodersen and co-workers showed that VapBC from
S. ﬂexneri pMYSH6000 forms a complex of similar stoi-
chiometry (Supplementary Figure S1C) (33). These
scientists also showed that VapBC binds to two operator
sites forming complexes of similar sizes. Figure 6 presents
a model explaining how the VapB/VapC ratio controls the
formation of the complex of VapBC with a single operator
site by conditional cooperativity. First, the strong co-
operative binding of VapBC to an operator site is ex-
plained by the two VapC dimers that bridge the two
VapB dimers each recognizing the operator half-sites.
Secondly, the bridging by the VapC dimers in the
complex makes VapC dimerization the controlling
element in the cooperative binding of the complex: with
an excess of VapB, a stable [(VapBC)2]2 complex binds
cooperatively to an operator site. In contrast, with an
excess of VapC, VapC destabilizes VapBC bound to an
operator site by invading the complex and breaking the
VapC dimer.
We challenged the model experimentally by alanine/
serine scanning of the patches in VapC responsible for
Figure 5. VapC dimerization is required for conditional cooperativity. (A) Predicted tertiary structure of a VapC dimer showing positions of amino
acid changes in the dimer interface. The predicted secondary structure of VapC is shown below the primary sequence. Amino acid patches involved
in dimerization are shown in blue and red, and amino acid substitutions in these patches are indicated by vertical arrows. (B) LacZ activities of
vapBC::lacZ transcriptional fusions carrying mutations in vapC. The genetic set-up of the transcriptional vapBC::lacZ fusion used is shown sche-
matically below the diagram. A broken arrow pointing rightward indicates the vapBC promoter. TB28 (MG1655lacZIYA) containing pKW254BC
(vapBC::lacZYA) or its isogenic vapC substitution mutant derivatives (see Supplementary Table S1) were grown exponentially in LB medium at 37 C
and speciﬁc LacZ activities were determined. (C) Gel shifts of vapO1 DNA with VapB and VapC (left panel) or VapC
Y72A (right panel). The proteins
were mixed with radio labelled vapO1 DNA in given concentrations (nM) (lanes 1–7). U and C indicate positions of unbound and bond complexes,
respectively. Right: Quantiﬁcation of C band intensities (%) seen in (C) as a function of lane number in the gel-shift shown at left.
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changes that were tested signiﬁcantly reduced transcrip-
tional repression by VapBC (Figure 5B), consistent with
the model. In particular, the Y72A change in VapC com-
pletely abolished repression. The corresponding amino
acid in VapC of N. gonorrhoea (P78) has previously
been shown to be important for VapC dimerization (29)
(Supplementary Figure S1B). We conﬁrmed that this was
also the case for VapC; VapC
Y72A only showed weak
dimerization in vitro (Supplementary Figure S3).
We conclude that VapC forms dimers, both in solution
and in the VapBCO repression complex.
We then analysed the VapC variants that exhibited a
reduced ability to repress transcription in vivo and in
in vitro (Figure 5B and C). The changes were dramatic:
The vapBC
Y72A operon was strongly de-repressed and,
consistently, the Y72A substitution reduced VapBC
complex formation with vapO1. Most importantly,
however, the binding-response of VapBC
Y72A was
non-cooperative and an excess VapC
Y72A did not desta-
bilize the VapBC
Y72AO complex (Figure 5C). A similar
abrogation of VapBCO complex destabilization was seen
with the other mutants that exhibited reduced transcrip-
tional repression in vivo (Supplementary Figure S4). Thus,
VapC dimerization is key, not only to repression but also
to derepression of vapBC transcription, that is, for condi-
tional cooperativity. These results support a model in
which both formation and destabilization of VapBCO is
controlled by VapC dimerization. In particular, destabil-
ization is caused by a VapC monomer switching partner
by pairing with a VapC monomer within the VapBCO
complex and thereby breaking the bridging dimer
required for strong and cooperative binding of VapBC
to vapO (Figure 6). In all cases, the amino acid
changes in VapC that conferred reduced repression
in vivo (Figure 5B) also abolished VapBCO destabilization
in vitro (Supplementary Figure S4). These results lend
further support to the model.
Conditional cooperativity has been described to control
TA operon transcription in three evolutionary independ-
ent gene families, ccd of F, relBE of E. coli and phd-doc of
P1 and is understood at the mechanistic level for all three
families (2,3,24,36). RelB antitoxin dimers bind relO
operator half-sites via their Ribbon–Ribbon–Helix
motifs (37). We previously proposed a model in which
RelE has two binding sites for RelB, a high-afﬁnity and
a low-afﬁnity site and that one RelE monomer bridges two
RelBs belonging to two different dimers bound to
operator half-sites (23). In this model, excess RelE
destabilized RelBEO by invasion of a second RelE
molecule into the complex by breaking the interaction
between the low-afﬁnity-site between RelE and RelB.
Thus, a high-afﬁnity interaction replaced a low-afﬁnity
interaction and was consistent with a very high efﬁciency
of complex destabilization—that is—RelBEO was
Figure 6. Molecular model explaining destabilization of the VapBC
complex bound to a single operator site by VapC. (i) VapC dimer
exist in an equilibrium with two VapC monomers. (ii) When VapC is
in excess of VapB, VapC monomers ‘invade’ the VapBCO complex.
(iii) Invasion abrogates cooperativity of VapBCO complex binding
and decreases the afﬁnity of VapBC for DNA. The structures shown
were modelled, using the known structure of the [(FitAB)2]2  DNA
complex (29).
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and at a ratio of approximately 2, the entire RelBEO
complex had disintegrated. In contrast, complete destabil-
ization of VapBCO occurred at a VapC/VapB ratio >16,
that is, destabilization of the VapBCO complex occurred
gradually and required a much higher relative level of
VapC. This considerably lower sensitivity of conditional
cooperativity in vapBC regulation can be explained by the
model in Figure 6: VapC is a dimer in solution that will be
in equilibrium with two monomers. The monomers will
also be in equilibrium with the dimers in VapBCO but
competition is in this case between molecules with identi-
cal afﬁnities, assuming that the dimer interface in a VapC
dimer is the same as that of a VapC dimer in VapBCO.
Therefore, in VapBCO, the VapC dimer equilibrium will
be pushed towards complex destabilization and dimer
breaking by high VapC concentrations. The observations
made in this study support that under conditions when
VapC is in excess of VapB, VapC can directly promote
transcription of vapBC and thereby stimulate VapB pro-
duction to help regenerate a balanced VapB/VapC ratio.
Whether this mechanism is active during physiological
conditions still needs to be tested.
Conditional cooperativity in the case of the phd-doc
operon control is understood at a profound mechanistic
level that lends support to the above-proposed model of
how RelE controls relBE transcription (24). Using a direct
structural approach, Remy Loris and colleagues showed
that Doc toxin has both a low-afﬁnity and high-afﬁnity
binding site for the C-terminus of the Phd antitoxin,
similar to what we postulated for the RelBE interaction
as described earlier. Structural analysis of Phd in the
presence and absence of Doc showed that binding of
Doc to Phd changed a partly disordered DNA binding
domain to an ordered one and thereby increased the
afﬁnity of Phd for is operator. Due to the second, low
afﬁnity binding-site in Doc, one Doc molecule is able to
bridge two Phd dimers bound to DNA and thereby confer
cooperativity. Thus, Doc has two separate effects on DNA
binding of Phd to its operator, both of which increase
binding. At a high Doc/Phd ratio, further Doc molecules
invade and destabilise the Doc–Phd–operator complex.
These considerations raise the possibility that the mech-
anisms by which Doc and RelE mediate conditional
cooperativity may be mechanistically related even
though the TA loci encoding these components evolved
independently. It is also clear from the results presented
here, that the molecular mechanisms of conditional
cooperativity in the cases of vapBC on the one hand and
phd-doc/relBE on the other are entirely different.
It has now become clear that conditional cooperativity
is a property common to TA loci (all TA loci investigated
so far are regulated by conditional cooperativity) and it is
relevant to ask how conditional cooperativity relates to
the biological function of TA loci. We showed recently
that TA loci that encode RNases are required for persist-
ence of E. coli (15). We proposed a model in which Lon, in
a minor fraction of the cells, degrade the antitoxins and
thereby induce toxin activity, dormancy and persistence
(drug tolerance). The vapBC locus has all the properties
required to function in persistence: it encodes a tRNase
whose activity inhibits translation reversibly (25,32) and
Lon degrades VapB antitoxin (Figure 1). It is not known
how bacterial cells resuscitate from the dormancy that is
characteristic of the persistent state (38). Persister cells
have higher TA transcription-rates than the average cell
population (39,40). This suggests that persisters have
increased T/A ratios and therefore raises the possibility
that conditional cooperativity is operative in persister
cells. It is thus possible that conditional cooperativity
secures a high, on-going transcription rate of TA loci in
dormant cells and thereby allow de novo synthesis of anti-
toxin that quench the toxins. By inference, such quenching
of the toxins must be required for the persisters to escape
dormancy and resuscitate. A second possibility, not
mutually exclusive with ﬁrst, is that conditional
cooperativity functions to rapidly turn off toxin activity
and TA operon transcription. The latter possibility would
also imply that conditional cooperativity help reduce
fortuitous events of toxin activation due to random
ﬂuctuations (noise) in the antitoxin level.
VapC activity and transcription of vapBC are both
regulated by Lon because the protease degrades VapB
antitoxin (Figure 1). It is not yet known if degradation
of VapB by Lon is controlled by cellular signals. It is
tempting to speculate that VapB degradation is actively
regulated by as yet unknown factors that control Lon
activity because such active regulation would enable the
cell to turn TA locus activity on and off according to
internal or external stimuli. We are now pursuing this
question.
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